Adrecizumab in Cardiogenic Shock
Conditions: Cardiogenic Shock; Endothelial Dysfunction Interventions: Biological: Adrecizumab; Drug: Placebo Sponsor: Dr. med. Mahir Karakas Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials